Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingo Ahrens

Showing results (11-20 of 103) with videos related to

Pageof 11
Sort By:
European Heart Journal. Acute Cardiovascular Care|September 1, 2022
Targeted temperature management: a transatlantic viewJanine Pöss, Ingo Ahrens
Current Opinion in Investigational Drugs (London, England : 2000)|August 26, 2009
Novel antiplatelet therapies following percutaneous coronary interventionsIngo Ahrens, Christoph Bode
European Heart Journal. Acute Cardiovascular Care|November 16, 2023
ESC Acute CardioVascular Care 2024 in AthensJanine Pöss, Ingo Ahrens
European Heart Journal. Acute Cardiovascular Care|June 3, 2022
Post congress highlights in acute cardiovascular care: a report from the American College of Cardiology 2022 scientific sessionsIngo Ahrens, Venu Menon
European Heart Journal. Acute Cardiovascular Care|August 17, 2023
Resuscitation-surviving with good neurological outcome: an interview with Prof. Jerry NolanJanine Pöss, Ingo Ahrens
Thrombosis and Haemostasis|May 2, 2008
Therapeutic integrin inhibition: allosteric and activation-specific inhibition strategies may surpass the initial ligand-mimetic strategiesIngo Ahrens, Karlheinz Peter
Nature Biotechnology|January 10, 2008
Humanizing mouse thrombiIngo Ahrens, Karlheinz Peter
Herz|May 20, 2005
[Direct inhibition of thrombin. A new strategy for the treatment of atrial fibrillation and acute coronary syndrome?]Ingo Ahrens, Christoph Bode
Current Drug Discovery Technologies|August 16, 2011
New parenteral anticoagulants: focus on factor Xa and thrombin inhibitorsIngo Ahrens, Christoph Bode
European Heart Journal. Acute Cardiovascular Care|May 8, 2023
The new acute cardiovascular care association study group EXPERT-PE on acute pulmonary embolismJanine Pöss, Ingo Ahrens
Pageof 11

Showing results (11-20 of 103) with videos related to

Sort By:
Pageof 11
European Heart Journal. Acute Cardiovascular Care|September 1, 2022
Targeted temperature management: a transatlantic viewJanine Pöss, Ingo Ahrens
Current Opinion in Investigational Drugs (London, England : 2000)|August 26, 2009
Novel antiplatelet therapies following percutaneous coronary interventionsIngo Ahrens, Christoph Bode
European Heart Journal. Acute Cardiovascular Care|November 16, 2023
ESC Acute CardioVascular Care 2024 in AthensJanine Pöss, Ingo Ahrens
European Heart Journal. Acute Cardiovascular Care|June 3, 2022
Post congress highlights in acute cardiovascular care: a report from the American College of Cardiology 2022 scientific sessionsIngo Ahrens, Venu Menon
European Heart Journal. Acute Cardiovascular Care|August 17, 2023
Resuscitation-surviving with good neurological outcome: an interview with Prof. Jerry NolanJanine Pöss, Ingo Ahrens
Thrombosis and Haemostasis|May 2, 2008
Therapeutic integrin inhibition: allosteric and activation-specific inhibition strategies may surpass the initial ligand-mimetic strategiesIngo Ahrens, Karlheinz Peter
Nature Biotechnology|January 10, 2008
Humanizing mouse thrombiIngo Ahrens, Karlheinz Peter
Herz|May 20, 2005
[Direct inhibition of thrombin. A new strategy for the treatment of atrial fibrillation and acute coronary syndrome?]Ingo Ahrens, Christoph Bode
Current Drug Discovery Technologies|August 16, 2011
New parenteral anticoagulants: focus on factor Xa and thrombin inhibitorsIngo Ahrens, Christoph Bode
European Heart Journal. Acute Cardiovascular Care|May 8, 2023
The new acute cardiovascular care association study group EXPERT-PE on acute pulmonary embolismJanine Pöss, Ingo Ahrens
Pageof 11